Aurinia Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUPH and other ETFs, options, and stocks.About AUPH
Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.
AUPH Key Statistics
Stock Snapshot
The current Aurinia Pharmaceuticals(AUPH) stock price is $15.63, with a market capitalization of 2.07B. The stock trades at a price-to-earnings (P/E) ratio of 7.54.
During the trading session on 2026-04-03, Aurinia Pharmaceuticals(AUPH) shares reached a daily high of $15.74 and a low of $15.06. At a current price of $15.63, the stock is +3.8% higher than the low and still -0.7% under the high.
Trading volume for Aurinia Pharmaceuticals(AUPH) stock has reached 1.26M, versus its average volume of 1.45M.
The stock's 52-week range extends from a low of $6.83 to a high of $16.54.
The stock's 52-week range extends from a low of $6.83 to a high of $16.54.
AUPH News
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Advertisement What Aurinia Pharmaceuticals offers and where it stands today Aurinia Pharmaceuticals (AUPH) focuses on therapies for autoimmune diseases, ancho...
Analyst ratings
57%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.